Search results for "transplant"

showing 10 items of 2137 documents

Case report of a large cephalic vein aneurysm inducing heart failure in a renal transplant patient with radio-cephalic fistula for haemodialysis

2020

Highlights • The venous aneurysm is one of the most common complications of autologous AVF. • The vein aneurysm should be treat by surgical resection and anastomotic ligature. • AVF shouldn’t be ligated from 1-year kidney transplantation except in some cases. • Surgical ligation to prevent complications could be considered an option.

medicine.medical_specialtycongenital hereditary and neonatal diseases and abnormalitiesFistulaArteriovenous fistulaCase ReportHeart failure03 medical and health sciences0302 clinical medicineAneurysmmedicinecardiovascular diseasesVeinKidney transplantationArteriovenous fistulaCephalic veinbusiness.industryRenal transplantationmedicine.diseaseSurgeryTransplantationmedicine.anatomical_structure030220 oncology & carcinogenesiscardiovascular system030211 gastroenterology & hepatologySurgerybusinessKidney diseaseSurgical repairInternational Journal of Surgery Case Reports
researchProduct

Rapid Steroid Withdrawal after Renal Transplantation Reduces Mortality: Five Year Follow-Up of a Randomized Controlled Trial (Harmony Study) Confirms…

2021

Background: We previously reported excellent efficacy and improved safety aspects of rapid steroid withdrawal (RSWD) in the randomized controlled one year “Harmony” trial, in which 587 predominantly deceased-donor kidney transplant recipients were randomized either to basiliximab or rabbit ATG induction therapy and compared to standard immunosuppressive therapy consisting of basiliximab, low tacrolimus once daily, mycophenolate mofetil, and corticosteroids. Methods: Following the end of the original one-year study period, patients were asked to participate in the observational follow-up (FU) study examining most of the end points of the original study. Hereby, de novo incidences between yea…

medicine.medical_specialtyeducation.field_of_studyBasiliximabbusiness.industryHazard ratioPopulationTacrolimuslaw.inventionTransplantationRandomized controlled triallawInternal medicinemedicineObservational studybusinesseducationSurvival ratemedicine.drugSSRN Electronic Journal
researchProduct

Bortezomib Retreatment in Relapsed Multiple Myeloma (MM): Results from a Binational, Multicenter Retrospective Survey

2008

Abstract In myeloma therapy retreatment after successful therapy is frequently considered. Here we present pooled data from a German and Swiss multicenter, retrospective survey (26866138MMY4014). The survey started in Germany and was later extended to Switzerland. German data have already been published before. Here we report on the entire cohort of patients for the first time. For inclusion into this analysis, patients with MM had to have had preceding bortezomib treatment, resulting in at least partial remission and a second therapy with Bortezomib on relapse. The intention of this trial was to provide further evidence of the value of a retreatment with bortezomib, description of predispo…

medicine.medical_specialtyeducation.field_of_studyIntention-to-treat analysisBortezomibbusiness.industryImmunologyPopulationCell BiologyHematologymedicine.diseaseBiochemistrySurgeryTransplantationConcomitantInternal medicinemedicineAdverse effecteducationbusinessMultiple myelomaDexamethasonemedicine.drugBlood
researchProduct

Predicting risk of acute rejection in patients with kidney transplants

2009

Objective: Create a model to predict the risk of acute rejection of kidney transplant considering variables related to the immunosuppressant agent used, the receiver, the donor, and the transplanted organ. Methods: Cohort study in a population of 68 patients with kidney transplants being treated with tacrolimus triple therapy. Predicting the risk of acute rejection was carried out with a logistic regression analysis using age, sex, retransplant status, number of HLA incompatibilities, cold ischaemia time, acute tubular necrosis, induction with basiliximab or thymoglobulin, and treatment type as explanatory variables. The contribution of variables associated with determining the blood concen…

medicine.medical_specialtyeducation.field_of_studyThymoglobulinBasiliximabbusiness.industryPopulationmedicine.diseaseLogistic regressionGastroenterologyTacrolimusSurgeryInternal medicinemedicineeducationbusinessKidney transplantationAcute tubular necrosismedicine.drugCohort studyFarmacia Hospitalaria (English Edition)
researchProduct

The evolution of European Medicines Agency drug approval: the adaptive licensing: Table 1

2015

In March 2014, the European Medicines Agency (EMA) launched a pilot project of ‘adaptive licensing’ to speed up access to drugs in development, in order to respond to unmet medical needs. The project will involve parallel scientific advice from the regulatory agency, pharmaceutical industry, the companies Health Technology Assessment (HTAs) bodies, organisations studying guidelines on clinical treatment and patient associations. The traditional process of drug authorisation is divided into several parts, involving in vitro studies and in vivo studies in animals (preclinical studies), as well as phase 1–3 randomised controlled trials conducted in humans over a predefined period. When authori…

medicine.medical_specialtyeducation.field_of_studybusiness.industryPopulationHealth technology030226 pharmacology & pharmacyClinical pharmacyTransplantation03 medical and health sciences0302 clinical medicineNursing030220 oncology & carcinogenesisFamily medicinePharmacovigilanceMedicineObservational studyGeneral Pharmacology Toxicology and PharmaceuticsbusinesseducationAdverse effectPharmaceutical industryEuropean Journal of Hospital Pharmacy
researchProduct

Allogeneic Hematopoietic Stem Cell Transplantation for T Cell Lymphomas: Improved Results Overtime

2019

INTRODUCTION: Allogeneic hematopoietic stem cell transplantation (alloSCT) is the only curative strategy for relapsed/refractory T cell lymphoma (T-NHL). In the past ten years, there have been several improvements in conditioning regimens and graft versus host disease prophylaxis (GVHD), which have contributed to lower transplant-related mortality (TRM). Also, selective and low toxicity therapies, might improve response quality in some T-NHL Recently, haploidentical stem cell transplantation (Haplo) with post-transplant cyclophosphamide is a new option for those patients who do not have an HLA-identical sibling or a suitable unrelated donor, but also it has shortened the time for urgent cas…

medicine.medical_specialtyeducation.field_of_studybusiness.industrymedicine.medical_treatmentImmunologyPopulationCell BiologyHematologyHematopoietic stem cell transplantationmedicine.diseaseBiochemistryTransplantationGraft-versus-host diseaseAutologous stem-cell transplantationMedian follow-upInternal medicinemedicineCumulative incidenceeducationbusinessProgressive disease
researchProduct

Non-invasive Diagnostic Approach to NASH: Biological Markers

2020

Non-alcoholic fatty liver disease (NAFLD) prevalence and incidence are dramatically increasing in parallel with the epidemics of both obesity and type 2 diabetes, accounting for the most growing cause of chronic liver disease, of hepatocellular carcinoma and of end-stage liver disease leading to liver transplantation. Natural history studies clearly demonstrated that among NAFLD population, those with non-alcoholic steatohepatitis (NASH) have a double risk of fibrosis progression, and that the severity of liver fibrosis is the main driver of hepatic and extrahepatic prognosis. Consistently, the availability of non-invasive markers to be used in NAFLD patients represents a relevant medical n…

medicine.medical_specialtyeducation.field_of_studymedicine.diagnostic_testbusiness.industrymedicine.medical_treatmentFatty liverPopulationDiseaseLiver transplantationmedicine.diseaseChronic liver diseaseGastroenterologyLiver diseaseInternal medicineLiver biopsymedicineSteatohepatitiseducationbusiness
researchProduct

O071 : Telomerase reverse transcriptase mutations are associated with hepatocellular carcinoma in nash

2015

O071 TELOMERASE REVERSE TRANSCRIPTASE MUTATIONS ARE ASSOCIATED WITH HEPATOCELLULAR CARCINOMA IN NASH B. Donati, E. Vanni, P. Dongiovanni, M. Iavarone, R. Rametta, C. Rosso, A. Carnelutti, S. Petta, A.L. Fracanzani, H.L. Reeves, J.F. Dofour, L. Miele, Q. Anstee, E. Bugianesi, G. Soardo, S. Fargion, L. Valenti. Pathophysiology and Transplantation, Universita degli Studi di Milano, Milano, Medical Sciences, University of Turin, Turin, Internal Medicine, Gastroenterology, Fondazione IRCCS Ca’ Granda, Milano, Internal Medicine, University of Udine, Udine, Gastroenterology, University of Palermo, Palermo, Italy; Medicine, Freeman Hospital, Newcastle Upon Tyne, United Kingdom; Clinical Research, U…

medicine.medical_specialtyfood.ingredientHepatologybusiness.industryGeneral surgerymedicine.diseaseVirologyTransplantationfoodNewcastle upon tyneHepatocellular carcinomamedicinePettaTelomerase reverse transcriptasebusinessJournal of Hepatology
researchProduct

Fertility protection: complications of surgery and results of removal and transplantation of ovarian tissue

2017

Fertility-preserving measures are becoming important for patients receiving oncological treatment. One method involves cryopreservation of ovarian tissue and transplanting it when treatment is completed. We report complications resulting from surgical and fertility medicine, and the results of procedures for the removal and transplantation of ovarian tissue carried out within the FertiProtekt network. A survey using a structured questionnaire was conducted among the FertiProtekt network centres between November 2015 and June 2016. The analysis included surgical techniques used to remove and transplant ovarian tissue, surgical complications and results. Laparoscopic removal and transplantati…

medicine.medical_specialtymedia_common.quotation_subjectFertilityOvaryMenstruation03 medical and health sciencesGynecologic Surgical Procedures0302 clinical medicinemedicineHumansFertility preservation610 Medicine & healthLaparoscopyOncofertilitymedia_common030219 obstetrics & reproductive medicinemedicine.diagnostic_testbusiness.industryOvaryFertility PreservationObstetrics and GynecologyCancermedicine.diseaseSurgeryTransplantationmedicine.anatomical_structureReproductive Medicine030220 oncology & carcinogenesisFemalebusinessDevelopmental BiologyReproductive BioMedicine Online
researchProduct

CT-Angiographie an einem 16-Schicht-CT zur perioperativen Evaluation der Leberarterien im Vergleich zur MR-Angiographie

2004

Purpose: To evaluate the efficiency of CT angiography (CTA) with 16-row MSCT compared with MR angiography (MRA) in analyzing the arterial anatomy in patients undergoing liver surgery. Materials and Methods: In 30 patients, MRA and CTA studies of the abdominal vessels were reviewed. CT parameters: slice thickness 3 mm; collimation 1.5; reconstruction interval 2 mm (Philips MX 8000 IDT); 120 ml contrast media (400 mg/ml) at a rate of 4 ml/ sec; acquisition of arterial-phase scans. The anatomy of the hepatic artery was evaluated from axial and reconstructed maximum-intensity-projection (MIP) images ("Slab-Viewer", Philips). MR parameters: contrast-enhanced coronal FLASH-3D sequences; slice thi…

medicine.medical_specialtymedicine.diagnostic_testImage qualitybusiness.industrymedicine.medical_treatmentPerioperativeLiver transplantationmedicine.anatomical_structureCoronal planeAngiographymedicineRadiology Nuclear Medicine and imagingMultislicecardiovascular diseasesRadiologyTomographybusinessArteryRöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren
researchProduct